Turner Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Turner Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-29,600	Closed	-$3.93M	–	251
2015 Q3	$3.93M	Hold	29,600	–	–	0.8%	44
2015 Q2	$5.21M	Sell	29,600 -1,840	-6%	-$330K	0.95%	24
2015 Q1	$5.43M	Sell	31,440 -10,780	-26%	-$1.85M	0.98%	22
2014 Q4	$6.91M	Sell	42,220 -29,563	-41%	-$4.91M	0.82%	18
2014 Q3	$11.5M	Buy	71,783 +12,116	+20%	+$1.86M	0.69%	27
2014 Q2	$8.77M	Buy	+59,667	New	+$8.27M	0.39%	62

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Herndon Capital Management Atlanta, Georgia $659M AUM 22.02% 1-Year Est. Return

Turner Investments's JAZZ Position: Q4 2015 in Review

Turner Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2015, closing a stake of 29,600 shares — an estimated $3.93M sold.

Turner Investments first reported a position in JAZZ in Q2 2014 and held it in 6 quarters. The position peaked at $11.5M in Q3 2014. 345 funds tracked by Wall St. Rank hold JAZZ as of Q4 2015.

Turner Investments reported no remaining Jazz Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Turner Investments sold 29,600 Jazz Pharmaceuticals shares in Q4 2015, an estimated $3.93M.
Turner Investments first reported a position in Jazz Pharmaceuticals in Q2 2014 and held it in 6 quarters.
Turner Investments's Jazz Pharmaceuticals position peaked at $11.5M in Q3 2014.
345 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2015.

Based on Turner Investments's 13F filing for Q4 2015, filed 9 Feb 2016.